substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- has been researched along with spectinabilin in 1 studies
Studies (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-) | Trials (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-) | Recent Studies (post-2010) (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-) | Studies (spectinabilin) | Trials (spectinabilin) | Recent Studies (post-2010) (spectinabilin) |
---|---|---|---|---|---|
20 | 0 | 1 | 12 | 0 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, JS; Liu, CX; Liu, SH; Wang, JD; Wang, XJ; Xiang, WS; Zhang, J; Zhao, JW | 1 |
1 other study(ies) available for substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- and spectinabilin
Article | Year |
---|---|
A new spectinabilin derivative with cytotoxic activity from ant-derived Streptomyces sp. 1H-GS5.
Topics: Animals; Antineoplastic Agents; Ants; Drug Screening Assays, Antitumor; HCT116 Cells; Hep G2 Cells; Humans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peptide Fragments; Pyrones; Streptomyces; Substance P | 2017 |